课题基金 / 基金详情

PHARMACOKINETICS OF ANTITUBERCULOSIS AGENTS IN HIV INFECTED PAITENTS WITH TB

PHARMACOKINETICS OF ANTITUBERCULOSIS AGENTS IN HIV INFECTED PAITENTS WITH TB
抗结核药物在 HIV 感染结核病患者中的药代动力学
批准号：
6117136
负责人：
GILDON N BEALL
金额：
$3.89万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6117136
关键词：
AIDS HIV infections antitubercular agents clinical research clinical trials gastrointestinal drug absorption human subject human therapy evaluation medical complication outcomes research pharmacokinetics secondary infection tuberculosis

项目摘要

项目成果

GILDON N BEALL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is not to test a new treatment, but to learn more about how medications used to treat tuberculosis are absorbed in HIV-infected persons. The relationship between the drug level in the blood and the outcome in subjects being treated for TB is not fully known. Subjects with TB who are HIV-infected will take part in this study and have the level of drugs in the blood measured.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG 328--RECOMBINANT HUMAN IL 2 BY IV OR SC IN HIV PATIENTS ON HAART
ACTG388 EFAVIRENZ OR NELFINAVIR IN COMBINATION W/ FIXED DOSE COMBINAT
PHYSIOLOGIC TESTOSTERONE REPLACEMENT IN HIV INFECTED WOMEN
PHASE I/II DOSING SAFETY AND ANTIVIRAL ACTIVITY OF HYDROSYUREA ALONE/COMBINED
海外基金